Health officials have touted a national stockpile of vaccines that work against monkeypox as well as smallpox, but getting them out to states and into the arms of people who need them has been a challenge.Īccording to a report from The New York Times, a hurdle in the monkeypox vaccine rollout (besides limited supply of Jynneos) is that the federal system being used to move vaccines to states and cities is different from the system local health officials are used to, which is run by the US Centers for Disease Control and Prevention and is already linked to state databases. But the change in medical guidance on how the monkeypox vaccine can be administered reflects a shortage of Jynneos that's plagued the vaccine rollout since it began. That's because the US Food and Drug Administration authorized intradermal injection for the monkeypox vaccine this month, which is an effort to increase the US supply of vaccine up to five times since intradermal injection requires a much smaller dose than one given subcutaneously.Īlso called "dose-sparing," intradermal types of injections aren't new to health care. If you're eligible for a monkeypox vaccine, you might be getting a shot under a top layer of skin, instead of deeper into your arm. The vaccine Jynneos is being given out a little differently now in some places. Some men who have sex with men are eligible for the vaccine, as are other people who may've been exposed to monkeypox. Access to vaccines is crucial for people most at risk. Vaccination is an important tool to slow the monkeypox outbreak happening in the US and other countries.
To stretch out more doses, the US is starting to administer the vaccine in a slightly different way that requires a smaller dose. The monkeypox vaccine is available to people at higher risk of getting the disease, but supply has been limited.
0 kommentar(er)
